Magnolia Capital Advisors LLC Has $1.47 Million Stock Holdings in CME Group Inc. (NASDAQ:CME)

Magnolia Capital Advisors LLC raised its stake in CME Group Inc. (NASDAQ:CME) by 3.2% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 7,131 shares of the financial services provider’s stock after buying an additional 224 shares during the quarter. Magnolia Capital Advisors LLC’s holdings in CME Group were worth $1,470,000 at the end of the most recent reporting period.

Several other large investors have also recently added to or reduced their stakes in CME. Morgan Stanley increased its stake in CME Group by 31.5% in the 3rd quarter. Morgan Stanley now owns 4,858,967 shares of the financial services provider’s stock valued at $972,863,000 after buying an additional 1,163,103 shares during the period. AEGON ASSET MANAGEMENT UK Plc bought a new stake in CME Group in the fourth quarter worth approximately $113,772,000. J.P. Morgan Private Wealth Advisors LLC bought a new stake in CME Group in the third quarter worth approximately $86,424,000. Barclays PLC grew its position in CME Group by 31.7% in the third quarter. Barclays PLC now owns 1,605,211 shares of the financial services provider’s stock worth $321,395,000 after acquiring an additional 386,730 shares in the last quarter. Finally, Invesco Ltd. boosted its holdings in shares of CME Group by 6.7% during the 3rd quarter. Invesco Ltd. now owns 3,465,422 shares of the financial services provider’s stock worth $693,847,000 after buying an additional 217,101 shares during the period. Institutional investors and hedge funds own 87.75% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research firms recently issued reports on CME. The Goldman Sachs Group downgraded shares of CME Group from a “neutral” rating to a “sell” rating and set a $195.00 price objective for the company. in a report on Wednesday, January 3rd. Keefe, Bruyette & Woods reaffirmed a “market perform” rating and set a $229.00 price objective on shares of CME Group in a report on Wednesday, April 3rd. Rosenblatt Securities reaffirmed a “sell” rating and set a $180.00 price objective on shares of CME Group in a report on Thursday, January 4th. Morgan Stanley increased their price target on shares of CME Group from $222.00 to $225.00 and gave the company an “equal weight” rating in a report on Tuesday, April 9th. Finally, Barclays increased their price target on shares of CME Group from $225.00 to $226.00 and gave the company an “equal weight” rating in a report on Monday, April 8th. Two equities research analysts have rated the stock with a sell rating, seven have given a hold rating and two have assigned a buy rating to the company’s stock. According to data from MarketBeat, CME Group currently has a consensus rating of “Hold” and an average price target of $215.70.

CME Group Price Performance

Shares of CME Group stock traded down $4.18 during mid-day trading on Wednesday, reaching $212.59. 2,636,858 shares of the stock were exchanged, compared to its average volume of 1,790,783. The company has a market cap of $76.53 billion, a price-to-earnings ratio of 23.97, a price-to-earnings-growth ratio of 6.06 and a beta of 0.49. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.13. The firm has a 50-day simple moving average of $214.73 and a 200 day simple moving average of $211.93. CME Group Inc. has a fifty-two week low of $175.73 and a fifty-two week high of $223.80.

CME Group (NASDAQ:CME) last announced its earnings results on Wednesday, February 14th. The financial services provider reported $2.37 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.27 by $0.10. The business had revenue of $1.44 billion during the quarter, compared to analysts’ expectations of $1.43 billion. CME Group had a net margin of 57.83% and a return on equity of 12.32%. The firm’s revenue for the quarter was up 19.2% on a year-over-year basis. During the same quarter last year, the company posted $1.92 EPS. On average, sell-side analysts predict that CME Group Inc. will post 9.58 EPS for the current fiscal year.

CME Group Increases Dividend

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, March 26th. Shareholders of record on Friday, March 8th were given a $1.15 dividend. This represents a $4.60 annualized dividend and a yield of 2.16%. The ex-dividend date was Thursday, March 7th. This is a boost from CME Group’s previous quarterly dividend of $1.10. CME Group’s dividend payout ratio (DPR) is presently 51.86%.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.